Li J - Search Results

1

Decreased background parenchymal enhancement of the contralateral breast after two cycles of neoadjuvant chemotherapy is associated with tumor response in HER2-positive breast cancer.

You C, Gu Y, Peng W, Li J, Shen X, Liu G, Peng W. You C, et al. Among authors: li j. Acta Radiol. 2018 Jul;59(7):806-812. doi: 10.1177/0284185117738560. Epub 2017 Oct 24. Acta Radiol. 2018. PMID: 29065702

2

Weekly paclitaxel/carboplatin/trastuzumab therapy improves pathologic complete remission in aggressive HER2-positive breast cancers, especially in luminal-B subtype, compared with a once-every-3-weeks schedule.

Yu KD, Liu GY, Chen CM, Li JW, Wu J, Lu JS, Shen ZZ, Shao ZM. Yu KD, et al. Among authors: li jw. Oncologist. 2013;18(5):511-7. doi: 10.1634/theoncologist.2012-0057. Epub 2013 May 1. Oncologist. 2013. PMID: 23635560 Free PMC article. Clinical Trial.

3

ER-poor and HER2-positive: a potential subtype of breast cancer to avoid axillary dissection in node positive patients after neoadjuvant chemo-trastuzumab therapy.

Li JW, Mo M, Yu KD, Chen CM, Hu Z, Hou YF, Di GH, Wu J, Shen ZZ, Shao ZM, Liu GY. Li JW, et al. PLoS One. 2014 Dec 11;9(12):e114646. doi: 10.1371/journal.pone.0114646. eCollection 2014. PLoS One. 2014. PMID: 25504233 Free PMC article.

4

Accumulation of p53 is prognostic for aromatase inhibitor resistance in early-stage postmenopausal patients with ER-positive breast cancer.

Jia XQ, Hong Q, Cheng JY, Li JW, Wang YJ, Mo M, Shao ZM, Shen ZZ, Liu GY. Jia XQ, et al. Onco Targets Ther. 2015 Mar 3;8:549-55. doi: 10.2147/OTT.S76879. eCollection 2015. Onco Targets Ther. 2015. PMID: 25767399 Free PMC article.

5

Indispensability of chemotherapy in estrogen receptor-negative early breast cancer in elderly women with diabetes mellitus.

Jia X, Hong Q, Cheng J, Li J, Wang Y, Mo M, Shao Z, Shen Z, Liu G. Jia X, et al. Among authors: li j. Diabetes Technol Ther. 2015 Apr;17(4):248-54. doi: 10.1089/dia.2014.0226. Diabetes Technol Ther. 2015. PMID: 25781236

6

Basal and therapy-driven hypoxia-inducible factor-1α confers resistance to endocrine therapy in estrogen receptor-positive breast cancer.

Jia X, Hong Q, Lei L, Li D, Li J, Mo M, Wang Y, Shao Z, Shen Z, Cheng J, Liu G. Jia X, et al. Among authors: li d, li j. Oncotarget. 2015 Apr 20;6(11):8648-62. doi: 10.18632/oncotarget.3257. Oncotarget. 2015. PMID: 25929338 Free PMC article.

7

Serum Tumor Marker Levels might have Little Significance in Evaluating Neoadjuvant Treatment Response in Locally Advanced Breast Cancer.

Wang YJ, Huang XY, Mo M, Li JW, Jia XQ, Shao ZM, Shen ZZ, Wu J, Liu GY. Wang YJ, et al. Among authors: li jw. Asian Pac J Cancer Prev. 2015;16(11):4603-8. doi: 10.7314/apjcp.2015.16.11.4603. Asian Pac J Cancer Prev. 2015. PMID: 26107211 Free article.

8

Nodal ratio of positive to excised nodes, but not number of positive lymph nodes is better to predict group to avoid chemotherapy among postmenopausal ER-positive, lymph node-positive T1-T2 breast cancer patients.

Jia XQ, Hong Q, Cheng JY, Li JW, Wang YJ, Mo M, Shao ZM, Shen ZZ, Liu GY. Jia XQ, et al. Among authors: li jw. J Cancer Res Ther. 2015 Oct-Dec;11(4):740-5. doi: 10.4103/0973-1482.154937. J Cancer Res Ther. 2015. PMID: 26881511 Free article.

9

Local recurrence following mastectomy and autologous breast reconstruction: incidence, risk factors, and management.

Wu S, Mo M, Wang Y, Zhang N, Li J, Di G, Shao Z, Wu J, Liu G. Wu S, et al. Among authors: li j. Onco Targets Ther. 2016 Nov 4;9:6829-6834. doi: 10.2147/OTT.S109356. eCollection 2016. Onco Targets Ther. 2016. PMID: 27853377 Free PMC article.

10

Sequential versus simultaneous use of chemotherapy and gonadotropin-releasing hormone agonist (GnRHa) among estrogen receptor (ER)-positive premenopausal breast cancer patients: effects on ovarian function, disease-free survival, and overall survival.

Zhang Y, Ji Y, Li J, Lei L, Wu S, Zuo W, Jia X, Wang Y, Mo M, Zhang N, Shen Z, Wu J, Shao Z, Liu G. Zhang Y, et al. Among authors: li j. Breast Cancer Res Treat. 2018 Apr;168(3):679-686. doi: 10.1007/s10549-018-4660-y. Epub 2018 Jan 13. Breast Cancer Res Treat. 2018. PMID: 29332135 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

190,767 results

Search Page

Filters